Paul McEwan

Table Mountain Capital LLC (Table Mountain Capital) is a venture capital firm founded in 2006. The firm is headquartered in Boulder, Colorado.

seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA.

Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett.

Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA.

Agencourt Bioscience Corp. provides genomic services and nucleic acid purification products. Its services enable biotechnology, pharmaceutical, government, and academic research laboratories to develop new drugs. The company was founded in July, 2000 by R. Brian McKernan, Kevin J. McKernan, and Brendan L. McKernan and is headquartered in Beverly, MA

Tangen Biosciences, Inc. develops portable instruments and methods for use in molecular diagnostics. Its instrument provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction amplification. The company was founded by John R. Nobile and John Davidson in 2013 and is headquartered in Branford, CT.

Part of Applied Biosystems, Inc., Agencourt Personal Genomics develops genetic analysis technologies. The company is based in Beverly, MA. The company was founded by Brendan L. McKernan, R. Brian McKernan, Kevin J. McKernan. Agencourt Personal Genomics was acquired by Applied Biosystems, Inc. /Old/ from Beckman Coulter, Inc. on July 11, 2006 for $120 million.